Hodges Capital Management Inc. Moderna, Inc. Transaction History

Hodges Capital Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$118.5 - $160.53 $1.35 Million - $1.82 Million	-11,358 Closed	0 $586,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $4.67 Million - $6.78 Million	-34,404 Reduced 75.18%	11,358 $1.51 Million
Q4 2022 Feb 03, 2023	BUY	$118.38 - $210.04 $4.59 Million - $8.14 Million	38,762 Added 553.74%	45,762 $8.22 Million
Q3 2022 Oct 21, 2022	SELL	$118.07 - $194.18 $112,166 - $184,471	-950 Reduced 11.95%	7,000 $828,000
Q2 2022 Jul 28, 2022	SELL	$117.13 - $176.59 $158,125 - $238,396	-1,350 Reduced 14.52%	7,950 $1.14 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $3.44 Million - $6.39 Million	-27,175 Reduced 74.5%	9,300 $4.39 Million
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $8.78 Million - $14.3 Million	-38,875 Reduced 51.59%	36,475 $9.26 Million
Q3 2021 Oct 06, 2021	BUY	$221.9 - $484.47 $4.96 Million - $10.8 Million	22,350 Added 42.17%	75,350 $29 Million
Q2 2021 Jul 06, 2021	BUY	$129.91 - $234.98 $6.89 Million - $12.5 Million	53,000 New	53,000 $12.5 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hodges Capital Management Inc. with notifications on news.